Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Code
  3. Website Naming
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Website Naming

Scheduled Pinned Locked Moved PAAB Code
2 Posts 2 Posters 338 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • G Offline
    G Offline
    GMC
    wrote on last edited by
    #1

    We have a situation where our brand has 2 indications in 2 different therapeutic areas. We wanted to run with brand.ca but realize that if a patient prescribed the brand for TA #1 is directed to the site, we can't mention the indications for TA #2 as that would link brand to indication for an indication that the patient was not prescribed. We were informed that this is the case when we tried to create an enrolment form that listed indications from 2 different TAs. I was wondering if PAAB has reviewed other brand sites with this situation and how it could be addressed in the URL.

    Jennifer CarrollJ 1 Reply Last reply
    0
    • G GMC

      We have a situation where our brand has 2 indications in 2 different therapeutic areas. We wanted to run with brand.ca but realize that if a patient prescribed the brand for TA #1 is directed to the site, we can't mention the indications for TA #2 as that would link brand to indication for an indication that the patient was not prescribed. We were informed that this is the case when we tried to create an enrolment form that listed indications from 2 different TAs. I was wondering if PAAB has reviewed other brand sites with this situation and how it could be addressed in the URL.

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by Jennifer Carroll
      #2

      Hi @gmc

      We have reviewed such sites. In general, the URL for the website (brand.ca) is to the homepage where gating can be started with the DIN number for the patient to enter. Once the patient is in the site, part 3 of the Product Monograph will dictate whether patients can see other therapeutic areas/ indications, i.e. is there only one part 3 for all indications or separate part 3s for separate indications? (we refer you to Section 1.1b of the Guidance on Branded Patient Information). If they are separate part 3's, then one suggestion is for the site to offer an option for the patient to enter their indication in order to enter the appropriate section.

      1 Reply Last reply
      0
      Reply
      • Reply as topic
      Log in to reply
      • Oldest to Newest
      • Newest to Oldest
      • Most Votes


      • Login

      • Don't have an account? Register

      • Login or register to search.
      • First post
        Last post
      0
      • Categories
      • Recent
      • Tags
      • Popular
      • Users
      • Groups